EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Critical Hypercytokinemia in Sepsis and Septic Shock: Identifying Interleukin-6 Thresholds Beyond Which Mortality Risk Exceeded Survival Probability

Critical Hypercytokinemia in Sepsis and Septic Shock: Identifizierung von Interleukin-6-Schwellenwerten, jenseits derer das Mortalitätsrisiko die Überlebenswahrscheinlichkeit überstieg

Juan Carlos Ruiz-Rodríguez iD, Luis Chiscano-Camón iD, Adolf Ruiz-Sanmartin, Natalia Costa-Allué iD, Ivan Bajaña, Pablo Nicolas-Morales iD, Juliana Bastidas, Sergi Cantenys-Molina iD, Manuel Hernández-Gonzalez, Nieves Larrosa, Juan Jose González-López iD, Vicent Ribas iD und 1 weitere

Journal of Clinical Medicine · 28.01.2026 · 15 (3) · 1057

DOI: 10.3390/jcm15031057 ↗

Auf einen Blick

Bei 1.669 Patient:innen mit Sepsis oder septischem Schock war IL-6 > 15.000 pg/mL mit höherer Mortalität verbunden. Ein kritischer Schwellenwert von 14.930 pg/mL wurde auf 15.000 pg/mL gerundet.

Fragestellung

Welcher IL-6-Schwellenwert ist bei Patient:innen mit Hyperinflammation mit einem signifikant erhöhten Sterberisiko assoziiert?

Methode

Retrospektive, monozentrische Beobachtungsstudie eines historischen Kollektivs erwachsener Patient:innen mit Sepsis-2, schwerer Sepsis oder septischem Schock; Analyse der IL-6-Werte und Überlebensdaten.

Ergebnisse

31 % Mortalität in 1.669 analysierten Patient:innen. Medianes IL-6: 772 pg/mL (IQR 164–8.750) bzw. 2.137 pg/mL bei Nichtüberlebenden (IQR 267–34.758). IL-6 > 15.000 pg/mL: OR 2,22 (95 %-KI 1,12–5,36); p < 0,0001 für Überleben.

Schlussfolgerung der Autor:innen

Bei Patient:innen mit schwerer Sepsis oder septischem Schock definierten IL-6-Werte > 15.000 pg/mL einen kritischen Schwellenwert, jenseits dessen das Mortalitätsrisiko die Überlebenswahrscheinlichkeit überstieg.

Kernaussagen

  • IL-6 > 15.000 pg/mL war mit höherer Mortalität assoziiert.
  • Kritischer Schwellenwert: 14.930 pg/mL, für die Praxis auf 15.000 pg/mL gerundet.
  • Die Überlebenswahrscheinlichkeit war oberhalb dieses Schwellenwerts reduziert.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.01.2026. Verfasst von Juan Carlos Ruiz-Rodríguez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with extremely elevated IL-6 levels remain poorly characterized, and no specific plasma concentration has been established to reliably predict mortality or guide immunomodulatory interventions. We hypothesized that extreme hypercytokinemia is associated with increased mortality in sepsis. The primary objective was to identify, in patients with hyperinflammatory endotype, an IL-6 threshold associated with a significantly elevated risk of death.

Methods

We conducted a retrospective, single-center observational study based on a historical cohort of adult patients with consecutive activation of the in-hospital sepsis code, a prospective and standardized institutional care pathway, at Vall d’Hebron University Hospital between July 2018 and December 2024. Patients fulfilling Sepsis-2 diagnostic criteria and criteria for severe sepsis or septic shock were eligible. Plasma interleukin-6 (IL-6) levels were routinely determined in all patients. The analysis included patients with complete clinical and laboratory data available in the study database. To identify the IL-6 threshold associated with critical risk of death, a cumulative conditional relative frequency analysis was performed. A quantile-based analysis was conducted using predefined intervals of 1000 pg/mL and 15,000 pg/mL. A multivariable logistic regression analysis was conducted to identify clinical and laboratory parameters independently associated with IL-6 > 15,000 pg/mL and outcome. Results are presented as odds ratios (ORs). Survival differences were assessed using Kaplan–Meier analysis.

Results

Overall mortality was 31% in the 1669 patients analyzed. Median IL-6 concentration was 772 pg/mL (IQR: 164–8750 pg/mL) with significantly higher levels in non-survivors (2137 pg/mL, IQR: 267–34,758). A critical IL-6 cutoff of 14,930 pg/mL was identified, which was rounded to 15,000 pg/mL for clinical applicability. IL-6 > 15,000 pg/mL was associated with increased mortality (OR 2.22, 95% CI: 1.12–5.36). Kaplan–Meier analysis revealed significantly reduced survival in patients above this IL-6 threshold (p < 0.0001).

Conclusions

In this cohort of patients with severe sepsis or septic shock, plasma IL-6 levels > 15,000 pg/mL defined a critical threshold beyond which mortality risk exceeded survival probability. Critical hypercytokinemia may serve as a clinically relevant biomarker to identify patients with sepsis and multiorgan dysfunction who could benefit from precision immunomodulatory therapies.

Schlagwörter

Stichwörter der Autor:innen

cytokine hemoadsorptionhypercytokinemiaimmunomodulationinterleukin-6septic shocksevere sepsis

Autor:innen und Institutionen

  • Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
  • Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
  • Immunology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
  • Microbiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
  • EHealth Unit, Eurecat, Centre Tecnològic de Catalunya, 08005 Barcelona, Spain.

ORCID-Profile: Juan Carlos Ruiz-Rodríguez, Luis Chiscano-Camón, Natalia Costa-Allué, Pablo Nicolas-Morales, Sergi Cantenys-Molina, Juan Jose González-López, Vicent Ribas, Ricard Ferrer

Zitieren

APA

Ruiz-Rodríguez, J. C., Chiscano-Camón, L., Ruiz-Sanmartin, A., Costa-Allué, N., Bajaña, I., Nicolas-Morales, P., Bastidas, J., Cantenys-Molina, S., Hernández-Gonzalez, M., Larrosa, N., González-López, J. J., Ribas, V., & Ferrer, R. (2026). Critical Hypercytokinemia in Sepsis and Septic Shock: Identifying Interleukin-6 Thresholds Beyond Which Mortality Risk Exceeded Survival Probability. Journal of Clinical Medicine, 15(3), 1057. https://doi.org/10.3390/jcm15031057

Vancouver

Ruiz-Rodríguez JC, Chiscano-Camón L, Ruiz-Sanmartin A, Costa-Allué N, Bajaña I, Nicolas-Morales P, et al. Critical Hypercytokinemia in Sepsis and Septic Shock: Identifying Interleukin-6 Thresholds Beyond Which Mortality Risk Exceeded Survival Probability. Journal of Clinical Medicine. 2026;15(3):1057. doi:10.3390/jcm15031057

BibTeX
@article{RuizRodrguez2026,
  author = {Ruiz-Rodríguez, Juan Carlos and Chiscano-Camón, Luis and Ruiz-Sanmartin, Adolf and Costa-Allué, Natalia and Bajaña, Ivan and Nicolas-Morales, Pablo and Bastidas, Juliana and Cantenys-Molina, Sergi and Hernández-Gonzalez, Manuel and Larrosa, Nieves and González-López, Juan Jose and Ribas, Vicent and Ferrer, Ricard},
  title = {Critical Hypercytokinemia in Sepsis and Septic Shock: Identifying Interleukin-6 Thresholds Beyond Which Mortality Risk Exceeded Survival Probability},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {1057},
  doi = {10.3390/jcm15031057}
}
Kostenlos starten →